Originalkatalog | Verfügbarkeit prüfen

LBA21 FOLFOX/FOLFIRI plus either bevacizumab or panitumumab in patients with initially unresectable colorectal liver metastases (CRLM) and left-sided and RAS/BRAFV600E wild-type tu...

Bond, M.J.G., Bolhuis, K., Loosveld, O.J.L., Droogendijk, H.J., de Groot, J.W.B., Hendriks, M.P., De Valk, B., Liem, M.S.L., Rijken, A.M., Verhoef, K., de Wilt, J.H.W., de Jong, K.P., Kazemier, G., van Amerongen, M.J., Engelbrecht, M.R.W., Klaase, J.M., Komurcu, A., Lopez-Yurda, M.I., Swijnenburg, R-J., Punt, C.J.A.
Veröffentlicht in: Annals of Oncology ; volume 33, page S1389 ; ISSN 0923-7534;
2022